As Johnson & Johnson (JNJ) Market Valuation Rose, Princeton Portfolio Strategies Group Has Cut by $609,408 Its Position; Summit Creek Advisors Has Upped Position in Monro (MNRO) as Valuation Rose

Monro, Inc. (NASDAQ:MNRO) Logo

Princeton Portfolio Strategies Group Llc decreased its stake in Johnson & Johnson (JNJ) by 5.16% based on its latest 2018Q3 regulatory filing with the SEC. Princeton Portfolio Strategies Group Llc sold 4,416 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 81,125 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $11.21M, down from 85,541 at the end of the previous reported quarter. Princeton Portfolio Strategies Group Llc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $345.31 billion market cap company. The stock increased 1.16% or $1.48 during the last trading session, reaching $128.75. About 833,277 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since December 31, 2017 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 23/05/2018 – JURY ALSO SAID J&J RESPONSIBLE FOR 67% OF PLAINTIFF’S AWARD; 05/04/2018 – JOHNSON & JOHNSON JNJ.N , IMERYS SA IMTP.PA ORDERED TO PAY $37 MLN IN NEW JERSEY CASE BLAMING TALC ON MESOTHELIOMA -COURTROOM VIDEO; 11/03/2018 – INVOKANA┬« (canagliflozin) Significantly Reduces the Risk of Heart Failure-Related Outcomes in Type 2 Diabetes Patients at Risk; 26/04/2018 – J&J BOOSTS QTR DIV TO 90C/SHARE FROM 84C/SHR, EST. 88C; 17/04/2018 – J&J QTRLY WORLDWIDE INVOKANA/INVOKAMET SALES $248 MLN VS $284 MLN REPORTED LAST YR; 17/04/2018 – J&J – QTRLY WORLDWIDE PHARMACEUTICAL SALES $9,844 MLN VS $8,245 MLN REPORTED LAST YR; 20/03/2018 – J&J CFO Dominic Caruso to retire, names Joseph Wolk as replacement; 30/04/2018 – Johnson & Johnson Vision Introduces Artificial-Intelligence Powered Virtual Assistant for Contact Lenses; 17/04/2018 – JNJ: NO GENERIC COMPETITION EXEPCTED FOR ZYTIGA IN 2018; 11/05/2018 – Natrecor (Nesiritide; Johnson & Johnson) Drug Outlook to 2025 – ResearchAndMarkets.com

Summit Creek Advisors Llc increased its stake in Monro Inc. (MNRO) by 7.91% based on its latest 2018Q3 regulatory filing with the SEC. Summit Creek Advisors Llc bought 16,680 shares as the company’s stock rose 11.30% while stock markets declined. The institutional investor held 227,671 shares of the consumer services company at the end of 2018Q3, valued at $15.85 million, up from 210,991 at the end of the previous reported quarter. Summit Creek Advisors Llc who had been investing in Monro Inc. for a number of months, seems to be bullish on the $2.25 billion market cap company. The stock decreased 0.15% or $0.1 during the last trading session, reaching $68.3. About 24,302 shares traded. Monro, Inc. (NASDAQ:MNRO) has risen 47.74% since December 31, 2017 and is uptrending. It has outperformed by 47.74% the S&P500. Some Historical MNRO News: 21/05/2018 – Monro’s (MNRO) CEO Brett Ponton Hosts Investor Day (Transcript); 21/05/2018 – MONRO, BUYS FREE SERVICE TIRE; 21/05/2018 – MONRO SEES FY 2018 ADJ. EPS $1.95 TO $2.00; 21/05/2018 – MONRO SEES FY 2018 SAME STORE SALES DOWN 0.5% TO UP 0.5%; 19/04/2018 – DJ Monro Inc, Inst Holders, 1Q 2018 (MNRO); 09/04/2018 – Monro at Company Marketing Hosted By Stephens Inc. Today; 21/05/2018 – Monro, Inc. Acquires Free Service Tire; 26/03/2018 – MONRO, NAMES EVAN NAYLOR AS COO; 21/05/2018 – MONRO COMPLETES PURCHASE OF FOUR WHOLESALE CENTERS; 02/04/2018 – Monro Company Marketing Scheduled By Stephens Inc for Apr. 9-11

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 22. They expect $1.95 earnings per share, up 12.07% or $0.21 from last year’s $1.74 per share. JNJ’s profit will be $5.23B for 16.51 P/E if the $1.95 EPS becomes a reality. After $2.05 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -4.88% negative EPS growth.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “Indian drug inspectors seize J&J baby powder – Seeking Alpha” on December 19, 2018, also Seekingalpha.com with their article: “J&J: Reuters story ‘false’ – Seeking Alpha” published on December 14, 2018, Seekingalpha.com published: “J&J: Lawsuits And Dividend Safety – Seeking Alpha” on July 27, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Dividend Champion Spotlight: Johnson & Johnson – Seeking Alpha” published on September 02, 2018 as well as Seekingalpha.com‘s news article titled: “Now Is The Time To Buy Johnson & Johnson – Seeking Alpha” with publication date: September 27, 2018.

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson had 108 analyst reports since August 7, 2015 according to SRatingsIntel. Barclays Capital downgraded the stock to “Equal-Weight” rating in Tuesday, November 29 report. Goldman Sachs upgraded the stock to “Neutral” rating in Thursday, July 12 report. The company was downgraded on Friday, July 21 by BTIG Research. The firm has “Outperform” rating by Credit Suisse given on Friday, April 20. The rating was maintained by Jefferies with “Hold” on Thursday, July 14. The rating was maintained by Piper Jaffray on Tuesday, July 18 with “Hold”. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Friday, March 23 by Jefferies. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) on Monday, July 10 with “Buy” rating. The rating was downgraded by Alembic to “Underweight” on Friday, July 21. The company was upgraded on Wednesday, July 20 by Argus Research.

Investors sentiment increased to 1.05 in 2018 Q3. Its up 0.08, from 0.97 in 2018Q2. It increased, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Morgan Stanley, a New York-based fund reported 22.92M shares. 236 were accumulated by Litman Gregory Asset Management Ltd Liability Corp. Pennsylvania Communications holds 2.38% in Johnson & Johnson (NYSE:JNJ) or 413,530 shares. Poplar Forest Capital Ltd Co invested in 16,657 shares. 354,784 are owned by South Dakota Inv Council. Stewart And Patten Com accumulated 5.12% or 202,132 shares. Moreover, Lathrop Invest Mgmt Corp has 0.1% invested in Johnson & Johnson (NYSE:JNJ) for 2,771 shares. The California-based Pacific Invest Mngmt Com has invested 2.36% in Johnson & Johnson (NYSE:JNJ). Forte Capital Ltd Liability Co Adv has 1.05% invested in Johnson & Johnson (NYSE:JNJ) for 21,077 shares. Lombard Odier Asset (Europe) Ltd stated it has 26,659 shares or 0.26% of all its holdings. Texas Permanent School Fund owns 602,247 shares or 1.15% of their US portfolio. Moreover, Hudock Cap Grp Inc Limited Company has 0.86% invested in Johnson & Johnson (NYSE:JNJ). Front Barnett Assocs Llc invested in 10,028 shares or 0.21% of the stock. Miracle Mile Advsr Limited Liability has 3,944 shares for 0.05% of their portfolio. Kames Cap Public Ltd Co invested in 0.69% or 209,771 shares.

Princeton Portfolio Strategies Group Llc, which manages about $199.15 million and $384.77 million US Long portfolio, upped its stake in Comcast Corp New (NASDAQ:CMCSA) by 29,867 shares to 291,468 shares, valued at $10.32M in 2018Q3, according to the filing. It also increased its holding in Church & Dwight Inc (NYSE:CHD) by 5,700 shares in the quarter, for a total of 18,100 shares, and has risen its stake in Pnc Finl Svcs Group Inc (NYSE:PNC).

Since August 27, 2018, it had 3 insider buys, and 8 selling transactions for $79.44 million activity. 748 shares were bought by MULCAHY ANNE M, worth $100,050. Duato Joaquin had sold 40,000 shares worth $5.77M. $536,638 worth of Johnson & Johnson (NYSE:JNJ) was sold by Kapusta Ronald A on Thursday, December 13. $4.41 million worth of stock was sold by Sneed Michael E on Friday, November 23. Another trade for 264,465 shares valued at $38.60M was sold by Gorsky Alex. $133,910 worth of stock was bought by PEREZ WILLIAM D on Friday, December 14.

Summit Creek Advisors Llc, which manages about $971.18 million and $624.21M US Long portfolio, decreased its stake in Medidata Solutions (NASDAQ:MDSO) by 51,960 shares to 112,860 shares, valued at $8.27 million in 2018Q3, according to the filing. It also reduced its holding in Balchem (NASDAQ:BCPC) by 27,210 shares in the quarter, leaving it with 61,963 shares, and cut its stake in Ultimate Software Group Inc. (NASDAQ:ULTI).

More notable recent Monro, Inc. (NASDAQ:MNRO) news were published by: Benzinga.com which released: “Monro Muffler (NASDAQ:MNRO) Has ‘Promising’ Unit Growth Potential, Goldman Sachs Says In Upgrade – Benzinga” on July 13, 2018, also Nasdaq.com with their article: “Monro Muffler Brake (MNRO) Tops Q2 Earnings and Revenue Estimates – Nasdaq” published on October 25, 2018, Globenewswire.com published: “Monro, Inc. Acquires Free Service Tire Nasdaq:MNRO – GlobeNewswire” on May 21, 2018. More interesting news about Monro, Inc. (NASDAQ:MNRO) were released by: Finance.Yahoo.com and their article: “Barron’s Picks And Pans: 2019 Picks, Emerging Markets, Small Caps And More – Yahoo! Finance News” published on December 15, 2018 as well as Globenewswire.com‘s news article titled: “Monro, Inc. and Amazon Expand Collaboration to Provide Tire Installation Services Across Eastern United States – GlobeNewswire” with publication date: October 11, 2018.

Investors sentiment decreased to 1.04 in Q3 2018. Its down 0.46, from 1.5 in 2018Q2. It fall, as 15 investors sold MNRO shares while 59 reduced holdings. 25 funds opened positions while 52 raised stakes. 36.24 million shares or 2.10% less from 37.02 million shares in 2018Q2 were reported. Maverick Ltd reported 68,832 shares or 0.06% of all its holdings. Neuberger Berman Grp Incorporated Lc owns 1.46M shares for 0.12% of their portfolio. Crawford Investment Counsel holds 0.14% in Monro, Inc. (NASDAQ:MNRO) or 66,783 shares. Massmutual Trust Fsb Adv owns 955 shares. Pinebridge Invests Limited Partnership, New York-based fund reported 41,823 shares. Td Asset Mngmt Incorporated reported 60,141 shares. Sei Invs reported 0.03% stake. Eaton Vance invested in 0.02% or 116,502 shares. Hanson Mcclain reported 0% in Monro, Inc. (NASDAQ:MNRO). Ls Limited Liability Com, Michigan-based fund reported 993 shares. National Bank Of Montreal Can stated it has 271,642 shares or 0.01% of all its holdings. Benjamin F Edwards And Inc holds 0% of its portfolio in Monro, Inc. (NASDAQ:MNRO) for 50 shares. Eagle Boston Inv Mgmt holds 1.51% or 240,819 shares. Summit Creek Advisors Ltd Co holds 227,671 shares or 2.54% of its portfolio. Sg Americas Ltd invested in 0.01% or 11,061 shares.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.